Добірка наукової літератури з теми "Obésité – Maladies – Lutte contre"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Obésité – Maladies – Lutte contre".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Obésité – Maladies – Lutte contre"
Charlot, Anouk, Rimel Boumiza, Margot Roux, and Joffrey Zoll. "Obésité, inflammation et COVID-19 : intérêt préventif de l’alimentation cétogène ?" Biologie Aujourd’hui 215, no. 1-2 (2021): 63–72. http://dx.doi.org/10.1051/jbio/2021004.
Повний текст джерелаMaillard, Jean-Charles. "La résistance génétique aux maladies animales." Revue d’élevage et de médecine vétérinaire des pays tropicaux 51, no. 2 (February 1, 1998): 106–8. http://dx.doi.org/10.19182/remvt.9633.
Повний текст джерелаMartin, Jean. "Obésité – œuvrer pour la santé contre les marchands de maladies." Revue Médicale Suisse 14, no. 611 (2018): 1251. http://dx.doi.org/10.53738/revmed.2018.14.611.1251.
Повний текст джерелаSimard, Frédéric. "La lutte contre les vecteurs : quel avenir ?" Biologie Aujourd'hui 212, no. 3-4 (2018): 137–45. http://dx.doi.org/10.1051/jbio/2019006.
Повний текст джерелаAymé, Ségolène. "Histoire des politiques de lutte contre les maladies rares." Les Tribunes de la santé N°62, no. 4 (2019): 23. http://dx.doi.org/10.3917/seve1.062.0023.
Повний текст джерелаTournier, Jean-Nicolas. "L’éradication des maladies infectieuses virales mise en danger par les avancées de la biologie synthétique." médecine/sciences 35, no. 2 (February 2019): 181–86. http://dx.doi.org/10.1051/medsci/2019005.
Повний текст джерелаLinks, MG. "Les données massives font évoluer la lutte contre les maladies infectieuses." Relevé des maladies transmissibles au Canada 41, no. 9 (September 3, 2015): 248–50. http://dx.doi.org/10.14745/ccdr.v41i09a03f.
Повний текст джерелаChristen, L., D. Detue, and Y. Yeuillaz. "Dépistage et prise en charge du syndrome métabolique chez des patients bénéficiant d’un neuroleptique d’action prolongée." European Psychiatry 28, S2 (November 2013): 49. http://dx.doi.org/10.1016/j.eurpsy.2013.09.128.
Повний текст джерелаJoël-Henri Gilles, Aloko-N’guessan Kouadio. "Lutte Contre Le Tabagisme Et Les Maladies Non Transmissibles En Côte d’Ivoire." European Scientific Journal, ESJ 14, no. 17 (June 30, 2018): 235. http://dx.doi.org/10.19044/esj.2018.v14n17p235.
Повний текст джерелаMignot, Hubert. "Réflexions sur des principes d'organisation de la lutte contre les maladies mentales." L'information psychiatrique 86, no. 5 (2010): 447. http://dx.doi.org/10.3917/inpsy.8605.0447.
Повний текст джерелаДисертації з теми "Obésité – Maladies – Lutte contre"
Le, Roy Tiphaine. "Implication du microbiote intestinal dans l’insulino-résistance et les pathologies hépatiques associées à l’obésité, étude sur modèle murin." Electronic Thesis or Diss., Paris, AgroParisTech, 2012. http://www.theses.fr/2012AGPT0016.
Повний текст джерелаObesity predisposes people to several severe pathologies, including type 2 diabetes and NAFLD (Non Alcoholic Fatty Liver Disease). Such pathologies are characterized by insulin resistance and systemic low grade inflammation. Recently, it has been established that such pathologies are associated to a gut microbiota dysbiosis. Moreover, recent studies in mice and human indicate that modulation of gut microbiota composition has beneficial effects on people suffering type 2 diabetes and/or NAFLD. Otherwise, it has been showed that germ-free mice remain lean, normo-glycemic and sensitive to insulin when fed a high-fat diet.The aim of this study was i) to decipher to what extent the pathogenesis of insulin resistance and NAFLD depends on the presence or absence of gut microbiota, ii) to determine if the predisposition to metabolic disorders in an obesity context can be transferred via gut microbiota transplantation.We first compared the response of germ-free and conventional mice to high fat diet. Indeed, germ-free mice appeared to be resistant to high-fat diet-induced obesity and insulin resistance. However, germ-freeness only partially protects against diet-induced steatosis, that is to say accumulation of triglycerides in hepatocytes. In conventional mice, high-fat diet induced an increase of the hepatic expression of genes involved in lipogenesis. The inverse phenomenon was observed in germ-free mice. In order to study the liver inflammation, we isolated and cultivated liver macrophages from the two groups of mice. As in conventional mice, high-fat diet induced an increased secretion of pro-inflammatory cytokines by germ-free mice liver macrophages. However, germ-free mice macrophages remained sensitive to LPS stimulation, which was not observed in the conventional mice group. This results demonstrates that being devoid of gut microbiota deeply alters the immunological and metabolic responses to high-fat diet. Therefore, differences in gut microbiota composition could explain the differences of susceptibility in diet-induced insulin-resistance and NAFLD.Then, we colonised two groups of germ-free mice with the gut microbiota of two conventional mice the responses of which to high-fat diet were discrepant. The two donors mice presented different levels of fasting glycemia and HOMA-IR index despite a similar body weight. Both groups of colonised mice developped comparable obesity but different degrees of fasting glycemia and insulin resistance. Levels of steatosis and hepatic expression of genes involved in lipogenesis were as well different in the two groups of colonised mice. Hence the results clearly show that the gut microbiota is the cause of the predisposition to diet-induced insulin resistance and hepatic steatosis. Gut microbiota analysis revealed a higher proportion of lactic acid bacteria, Atopobium, Bacteroides and Akkermansia muciniphila in receiver mice resistant to diet-induced insulin resistance and steatosis, which allow us to hypothesize a protective effect of these bacteria in diet-induced metabolic disorders
Alaphilippe, Aude. "Effets secondaires de l'utilisation d'un agent de lutte biologique : rôle des metabolites primaires de surfaces des feuilles dans l'interaction entre l'agent de lutte biologique et Cydia pomonella L." Paris, AgroParisTech, 2008. http://www.theses.fr/2008AGPT0039.
Повний текст джерелаFraser, Pierre. "Les conditions d’émergence de la lutte contre l’obésité." Doctoral thesis, Université Laval, 2016. http://hdl.handle.net/20.500.11794/26807.
Повний текст джерелаMasih, Emmanuel Isaac. "Lutte biologique contre Botrytis cinerea, agent de la pourriture grise de la vigne." Dijon, 2005. http://www.theses.fr/2005DIJOS049.
Повний текст джерелаGrey mould disease caused by Botrytis cinerea is one of the most important diseases of the grapevine. The intensive use of the chemical products to irradicate the grey mould disease resulted in environmental pollution, and appearence of the resistant varieties of the pathogen. This study of research showed the antagonism between the B. Cinerea and the bacteria and yeast, and the different isolates of the genus Pythium. The selected antagonistic microbes to Botrytis cinerea, were identified using morphological as well as genetical tools and the study of their mode of action was initiated. The enzymatic activities and the elicitation capability were also studied. These activities have a direct relationship with the trigerring of the natural defence mechanisms of the grapevine. In the following context, the use of the selected micorobes as biocontrol agents can be undertaken for the effective control of Botrytis cinerea
Blanchard-Louis, Claire. "Effets de la chirurgie bariatrique sur le métabolisme du cholestérol." Thesis, Nantes, 2016. http://www.theses.fr/2016NANT1020/document.
Повний текст джерелаObesity is a major public health issue, with increasing prevalence. Metabolic complications such as type 2 diabetes, hypertension and dyslipidemia are frequently associated with morbid obesity. Bariatric surgery represents the therapeutic alternative of choice for these patients. Clinical studies show thatplasma cholesterol is clearly improved after surgery. Interestingly, the magnitude of reduction depends on the surgical techniques used suggesting that cellular and molecular mechanisms involved are different. Using mouse models,we demonstrated that Roux en Y Gastric Bypass (RYGB) strongly lowers plasma cholesterol compared to sleeve gastrectomy. RYGB increases fecal cholesterol excretion via the stimulation of trans intestinal cholesterol excretion (TICE) and a reduction of intestinal cholesterol absorption. In this context, and expanding in the management of hypercholesterolemia, TICE seems to be an interesting therapeutic target.In parallel with this work, we assessed, in collaboration with members of INSERM unit 913 (Dr Neunlist), the short-term effect of sleeve gastrectomy on intestinal barrier. We show that sleeve gastrectomy induces significant modifications of intestinal para and transcellular permeability by altering the expression of proteins involved in tight junctions. These changes favor plasma LPS translocation promoting a low grade pro-inflammatory state in adipose tissue. These effects of sleeve gastrectomy on intestinal permeability remain to be assessed after a longer post-surgical period
Capini, Christelle. "Immunisation active anti-cytokine dans la lutte contre les maladies auto-immunes." Paris 6, 2003. http://www.theses.fr/2003PA066395.
Повний текст джерелаPelat, Thibaut. "Obtention et ingénierie d'anticorps recombinants thérapeutiques et/ou prophylactiques dirigés contre les agents du risque biologique provoqué." Montpellier 2, 2009. http://www.theses.fr/2009MON20093.
Повний текст джерелаRecombinant antibodies isolated from non-human primates represent very promising medical countermeasures against bioweapons. The advantages and methodological aspects of this approach have been described. An scFv, neutralizing the lethal toxin of Bacillus anthracis (2LF: KD= 1. 02 nM) and directed against the “lethal factor” subunit was isolated from a phage-displayed immune library, and characterised. Another scFv, 43RCA, neutralizing ricin, was obtained with the same methodology and tested (in particular: KD= 40 pM). This approach may also be used beyond bioweapons, as an scFv directed toward Aspergillus fumigatus was also isolated (MS130i-IIIC3: KD= 0,96 nM). On-line sequence analysis with IMGT tools allowed to show the high degree of similarity between these scFvs and their human counterparts. Antibody fragments were engineered, including an in vitro affinity maturation (KD initial = 3. 4 nM; KD final = 0. 18 nM). Utilizing IMGT standardisation and on-line tools, a “germline humanization” - utilizing FR derived from IgM, encountered by every Human, as opposed to IgG FR - was realized in order to ensure an optimal tolerance for one of our scFvs. A primatized IgG was tested in vivo and showed therapeutic and prophylactic capacities
Bourgouin, Catherine. "Les Toxines de Bacillus thuringiensis israelensis et de Bacillus sphaericus leur utilisation en lutte biologique contre les vecteurs de maladies tropicales /." Grenoble 2 : ANRT, 1988. http://catalogue.bnf.fr/ark:/12148/cb376121877.
Повний текст джерелаSy, Abdoul Aziz. "Lutte biologique contre la pyriculariose du riz (Pyricularia oryzae cav. ) : stratégie et applications." Toulouse, INPT, 1987. http://www.theses.fr/1987INPT025A.
Повний текст джерелаBabi, Adnan. "Bioécologie de Trichogramma Cacoeciae Marchal et T. Daumalae Dugats et Voegele (Hym. Trichogrammatidae) : utilisation en lutte biologique contre Lobesia Botrana Den. et Schief. (Lef. Tortricidae)." Aix-Marseille 3, 1990. http://www.theses.fr/1990AIX30032.
Повний текст джерелаКниги з теми "Obésité – Maladies – Lutte contre"
Petit, Marie-Magdeleine. Histoire de la lutte contre les maladies infectieuses depuis Pasteur. Paris: Ellipses, 2012.
Знайти повний текст джерелаLavallée, Robert. Lutte contre le charançon du pin blanc: Intervention et lutte biologique. Sainte-Foy, Qué: Centre de foresterie des Laurentides, 1997.
Знайти повний текст джерелаSauvez votre jardin. Paris: De Vecchi, 2008.
Знайти повний текст джерелаMbodj, Yamar. La lutte intégrée contre les maladies du riz en Casamance au Sénégal. Dakar, Senegal: Institut sénégalais de recherches agricoles, 1989.
Знайти повний текст джерелаBeauvais, Michel. Les pires cauchemars du jardinier: [l'invasion a déjà commencé]. Paris: "Rustica" éd., 2013.
Знайти повний текст джерелаBrochard, Daniel. SOS plantes. Paris: Sélection du "Reader's digest, 2002.
Знайти повний текст джерелаReid, Lana M. Maladies courantes du maïs au Canada. Ottawa, Ont: Agriculture et agroalimentaire Canada, 2001.
Знайти повний текст джерелаBerthiaume, Richard. Le puceron des pousses du sapin. Sainte-Foy, Qué: Centre de foresterie des Laurentides, 2001.
Знайти повний текст джерелаsida, Centre québécoisde coordination sur le. Stratégie québécoise de lutte contre le SIDA et de prévention des maladies transmissibles sexuellement. [Québec]: Gouvernement du Québec, Ministère de la santé et des services sociaux, Centre québécois de coordination sur le SIDA, 1992.
Знайти повний текст джерелаLe paludisme: La lutte mondiale contre un parasite résistant. Paris: L'Harmattan, 2008.
Знайти повний текст джерелаЧастини книг з теми "Obésité – Maladies – Lutte contre"
"7. La lutte contre les maladies infectieuses." In Le mauvais air, 231–92. EDP Sciences, 2022. http://dx.doi.org/10.1051/978-2-7598-2679-7.c009.
Повний текст джерелаCADDEO, Julie. "L’action des pouvoirs locaux face aux crises épidémiques au XVIIIe siècle." In Les épidémies au prisme des SHS, 99–108. Editions des archives contemporaines, 2022. http://dx.doi.org/10.17184/eac.5995.
Повний текст джерелаHussey, N. W., and H. J. Gould. "Techniques de Lutte Intégrée Contre les Ravageurs et les Maladies des Legumes Cultives Sous Serre et Examen de Leur Mise en Oeuvre Commerciale." In Integrated Crop Protection, 292–95. CRC Press, 2020. http://dx.doi.org/10.1201/9781003079033-68.
Повний текст джерела